Work

Vedolizumab does not reduce the CD4+:CD8+ ratio in the CSF of healthy volunteers

Year: 2011

Type: article

Study design: Clinical Trial

Source: Inflammatory Bowel Diseases

DOI: 10.1097/00054725-201112002-00173

Authors: Catherine Milch, Tim Wyant, Jing Xu, Whitney Kent, Joseph Berger, Irving Fox

Institutions: Takeda Oncology (United States), University of Kentucky

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2331501095

FWCI: 0.799

Cites:

Cited by: 11

Related to: 10